Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amag Pharmaceuticals (NQ: AMAG )

13.75 USD UNCHANGED
Last Price Updated: 4:06 PM EST, Nov 13, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Amag Pharmaceuticals

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
AMAG Pharmaceuticals Announces FDA Approval of New Single-Dose, Preservative-Free Makena® (hydroxyprogesterone caproate injection)
Company Plans for Full Commercial Launch of Makena Line Extension in Second Quarter of 2016 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by AMAG Pharmaceuticals, Inc. and Certain Officers and Directors -- AMAG
Tags Business & Professional Services
From ACCESSWIRE
AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care, today... 
From GlobeNewswire News Releases
Who Will Come Out On Top As Flu Season Draws Down
Tags Publishing & Media
From ACCESSWIRE
AMAG Pharmaceuticals to Host Conference Call on February 17, 2016 at 8:00 a.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2015
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will report unaudited consolidated financial results for the fourth quarter and year ended December 31, 2015 before the U.S. financial... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences... 
From GlobeNewswire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by AMAG Pharmaceuticals, Inc. and Certain Officers and Directors -- AMAG
Levi & Korsinsky, LLP announces that it has commenced an investigation of AMAG Pharmaceuticals, Inc. ("AMAG Pharmaceuticals" or the "Company") (NASDAQGS: AMAG) concerning possible violations of federal... 
From PR Newswire
AMAG Pharmaceuticals Announces Preliminary 2015 Financial Results and Provides 2016 Financial Guidance
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today provided a business update, announced preliminary unaudited fourth quarter and annual 2015 financial results and provided 2016 financial guidance. The... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces $60 Million Share Repurchase Program
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that its Board of Directors has approved a share repurchase program under which AMAG may purchase up to $60 million of its common stock. The... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, AMAG’s chief executive officer, will present at the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13,... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Appoints Nicholas Grund as Chief Commercial Officer
Key Commercial Leadership Changes to Drive Future Business Growth 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Awards Grants to Fund Prematurity Prevention Research
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the company has awarded $155,000 in grants to fund research aimed at reducing premature birth and improving the health of neonates and... 
From GlobeNewswire News Releases
Equities Lead Investor Sentiment -- Free Research on AEterna Zentaris, AMAG Pharmaceuticals, Performant Financial and Glu Mobile
Tags Business & Professional Services
From ACCESSWIRE
AMAG Pharmaceuticals Responds to Recent Complete Response Letter From the FDA for the Single-Dose, Preservative-Free Vial of Makena(R)
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that it responded to the U.S. Food and Drug Administration (FDA), providing the information and data requested in the Complete Response Letter... 
From GlobeNewswire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud by AMAG Pharmaceuticals, Inc. and Certain Officers and Directors
Levi & Korsinsky, LLP announces that it has commenced an investigation of AMAG Pharmaceuticals, Inc. concerning possible violations of federal securities laws 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG
Tags Business & Professional Services
From ACCESSWIRE
AMAG Pharmaceuticals Receives Complete Response Letter From FDA for Single-Dose, Preservative-Free Vial of Makena(R) (hydroxyprogesterone caproate injection)
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for its application seeking approval for a single-dose vial of... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Participate in the Jefferies Autumn 2015 Global Healthcare Conference in London
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, AMAG's chief executive officer, will present at the Jefferies Autumn 2015 Global Healthcare Conference in London on... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Reports Third Quarter 2015 Financial Results
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today reported unaudited consolidated financial results for the third quarter and year-to-date periods ended September 30, 2015. Total revenues for the third... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Head-to-Head Phase 3 Clinical Trial Evaluating Feraheme(R) in Adults With Iron Deficiency Anemia
Clinical Trial Marks Step Forward on the Pathway to Pursue a Broader Feraheme(R) Label 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Host Conference Call on November 3, 2015 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Nine Months Ended September 30, 2015
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will report unaudited consolidated financial results for the quarter and nine months ended September 30, 2015 before the U.S. financial... 
From GlobeNewswire News Releases
Equities Review on the Healthcare Sector -- AMAG Pharmaceuticals, Halozyme Therapeutics, Amarin, Epizyme and EXACT Sciences
From PR Newswire
Stocks Update from Health Care Sector -- Halozyme Therapeutics, Celldex Therapeutics, Galena Biopharma, AMAG Pharmaceuticals and EXACT Sciences
From PR Newswire
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
AMAG Pharmaceuticals Appoints Joseph Vittiglio as General Counsel and Secretary
From GlobeNewswire News Releases
AMAG Pharmaceuticals Completes Acquisition of Cord Blood Registry
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Pricing of Private Offering of $500 Million of Senior Notes Due 2023
From GlobeNewswire News Releases
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Shareholder Alert: Investigation Concerning Possible Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 08/12/2015 -- An investigation for investors in NASDAQ:AMAG shares over potential securities laws violations by AMAG Pharmaceuticals and certain of its directors and... 
From SBWire - Latest Press Releases
AMAG Pharmaceuticals Announces Closing of $231 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Proposed Private Offering of $450 Million of Senior Notes Due 2023
From GlobeNewswire News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.